Jaydess is an intrauterine spiral based on levonorgestrel, which includes 13 milligrams of the active substance. Within 24 hours, 20 mcg of the active substance is released and thanks to this, the result of the action of the product is calculated for 3 years of contraceptive action. Under the action of the hormone, the properties and structure of the uterine myometrium change, and the egg cannot fertilize.
What happens inside the body after the administration of Jaydess.
The product may affect the menstrual cycle due to the action of levonorgestrel on the uterine endometrium. In the process of hormonal changes in endometrial proliferation, blood flow during menstruation may increase over time. Subsequently, there is a contraction and the body returns to normal functioning. The ovaries remain in working order and the usual level of estradiol is maintained.
Can I change a product without harming my health?
The Jaydess remedy may be entered only by a professional who has received medical education. The product is administered in seven days after starting of menstruation. You can replace it at any time of the menstrual cycle. The system is allowed to enter after the abortion. If there is pain or bleeding during or after administration, a physical examination and ultrasound should be performed immediately, and if complications occur, remove the product.
The Jaydess system is removed with a surgical forceps. If the filaments extending from the Jade spiral are inconspicuous or the system is in the uterine cavity, then it can be pulled out with wide forceps. The system must be pulled out before the product expiration date to avoid any complications. If the patient wishes to continue using the product, a new system can be entered.
What are the contraindications to the use of Jaydess?
It is forbidden to enter the product if the patient is pregnant, there are inflammatory diseases of the pelvic organs or diseases of infectious type, there is acute cervicitis or vaginitis, the development of malignant tumors of the cervix, progestogen-dependent tumors or pathological vaginal bleeding, diseases of the liver.
